Excel Industries Limited

rs,

xcel Industries Ltd. 11th February, 2025 BSE Ltd. Listing Department, Pheeroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400 001 Sub: Investor Presentation IS/ISO9001:2015 IS/ISO14001:201

₹ 12

ss. 2 Q3 & 9M FY25 Financial Performance 3 Q3 & 9MFY25 Results Highlights (Standalone) Q3FY25 ₹ 12 Crs EBITDA ₹ 196 Crs Revenue ₹ 6 Crs PAT ₹ 730 Crs Revenue 9MFY25 ₹ 101 Crs EBITDA ₹ 72

₹ 196

25 Financial Performance 3 Q3 & 9MFY25 Results Highlights (Standalone) Q3FY25 ₹ 12 Crs EBITDA ₹ 196 Crs Revenue ₹ 6 Crs PAT ₹ 730 Crs Revenue 9MFY25 ₹ 101 Crs EBITDA ₹ 72 Crs PAT • • •

₹ 6

nce 3 Q3 & 9MFY25 Results Highlights (Standalone) Q3FY25 ₹ 12 Crs EBITDA ₹ 196 Crs Revenue ₹ 6 Crs PAT ₹ 730 Crs Revenue 9MFY25 ₹ 101 Crs EBITDA ₹ 72 Crs PAT • • • • • In Q3 FY25, t

₹ 730

MFY25 Results Highlights (Standalone) Q3FY25 ₹ 12 Crs EBITDA ₹ 196 Crs Revenue ₹ 6 Crs PAT ₹ 730 Crs Revenue 9MFY25 ₹ 101 Crs EBITDA ₹ 72 Crs PAT • • • • • In Q3 FY25, the Company achie

₹ 101

andalone) Q3FY25 ₹ 12 Crs EBITDA ₹ 196 Crs Revenue ₹ 6 Crs PAT ₹ 730 Crs Revenue 9MFY25 ₹ 101 Crs EBITDA ₹ 72 Crs PAT • • • • • In Q3 FY25, the Company achieved a revenue of ₹196 Crs re

₹ 72

₹ 12 Crs EBITDA ₹ 196 Crs Revenue ₹ 6 Crs PAT ₹ 730 Crs Revenue 9MFY25 ₹ 101 Crs EBITDA ₹ 72 Crs PAT • • • • • In Q3 FY25, the Company achieved a revenue of ₹196 Crs representing a 27% d

₹196

Y25 ₹ 101 Crs EBITDA ₹ 72 Crs PAT • • • • • In Q3 FY25, the Company achieved a revenue of ₹196 Crs representing a 27% decline from Q2 FY25. The decline was on account of lower demand due to inv

27%

₹ 72 Crs PAT • • • • • In Q3 FY25, the Company achieved a revenue of ₹196 Crs representing a 27% decline from Q2 FY25. The decline was on account of lower demand due to inventory destocking in a

21%

king in agro market coupled with reduction in sales prices of key product. The exports revenue was 21% and 17% of total revenue in Q3 FY 25 and 9M FY 25 respectively. The company's EBITDA margins stood

17%

agro market coupled with reduction in sales prices of key product. The exports revenue was 21% and 17% of total revenue in Q3 FY 25 and 9M FY 25 respectively. The company's EBITDA margins stood at 6.3%

6.3%

17% of total revenue in Q3 FY 25 and 9M FY 25 respectively. The company's EBITDA margins stood at 6.3% & 13.8% for Q3 FY25 & 9M FY25 respectively. Declined margins were a result of lower volume and in

“* FICCI Avendus Report # McKinsey report 2019 29 …Indian industry growing at double digit The Indian chemical industry is expected to reach $304 billion by 2025, growing at a CAGR of 9.3%.”

“8 lakh crore (US$ 107.38 billion) is estimated in the Indian chemicals and petrochemicals sector by 2025 & 7-9% growth is expected in FY25 (Source: IBEF & TOI) The Indian Specialty Chemical Industry was valued at $41Bn in 2021 and is projected to reach $72Bn by 2026, growing at a CAGR of 12.4% from 2021 to 2026.”

“$72 Billion CAGR 12.4% Exports and revenue from India are predicted to grow 18- 20% .”

Source

2

Investor Relations Advisors

1

Source

1. 2. @ IBEF 3. * FICCI Avendus Report # McKinsey report 2019 29 …Indian industry growing at double digit The Indian chemical industry is expected to reach $304 billion by 2025, growing at a CAGR of 9.3%. (Source: TOI) Market share of India to grow to 6% by 2026. (Source: CRISIL) India is expected to remain a driving force in Asia for chemical demand in 2024 given its strong economic growth and resilient industrial production and greater demand. India’s specialty chemicals companies are expanding their capacities to cater to rising demand from domestic and overseas Domestic growth in the sector is predicted to be at 13- 15% . (Source: CRISIL) An investment of Rs. 8 lakh crore (US$ 107.38 billion) is estimated in the Indian chemicals and petrochemicals sector by 2025 & 7-9% growth is expected in FY25 (Source: IBEF & TOI) The Indian Specialty Chemical Industry was valued at $41Bn in 2021 and is projected to reach $72Bn by 2026, growing at a CAGR of 12.4% from 2021 to 2026. $72 Billion CA

Source

1. 2. @ IBEF 3. * FICCI Avendus Report # McKinsey report 2019 2021 2026 30 Historical Financial Performance 31 Historical Performance REVENUE (Rs in Crs) EBITDA (Rs in Crs) PAT (Rs in Crs) (Standalone) Chemicals ENBT 1.178 1.090 702 749 685 730 1.153 1.067 826 812 18 2020 20 2021 25 2022 23 2023 14 2024 230 160 129 121 127 93 70 78 24 15 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 REVENUE MIX Chemicals(Rs in Crs) EBITDA Margin (%) PAT Margin (%) 857 841 516 599 169 2020 131 2021 295 2022 Domestic 226 2023 Export 684 128 2024 18% 16% 20% 13% 14% 12% 3% 9% 7% 2% 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 32 Historical Performance Return on Capital Employed Return on Equity (Standalone) 34% 24% 19% 14% 3% 23% 19% 13% 10% 2% 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 WORKING CAPITAL ANALYSIS# 78 84 55 40 60 34 62 56 51 52 36 44 *82 *82 *47 2020 2021 2022 2023 2024 Receivable Days Payable Days Inventory Days *Higher due to increase in operations in Q4 FY 24 in comparison

Investor Relations Advisors

Excel Industries Limited CIN: L24200MH1960PLC011807 Mr. Devendra Dosi, CFO Chief Financial Officer Email: devendra.dosi@excelind.com Mr. Bhavya Shah: +91 8082748577 bhavya.shah@linkintime.co.in Ms. Shiwani Karwat: +91 9833251393 Shiwani.karwat@linkintime.co.in www.excelind.co.in www.orientcap.com